This is a partial preview. Full document is 31 slides. View large preview.
EMBED CODE (Copy and Paste)
The breast cancer therapy market was the largest in oncology across the major markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) in 2015 with sales of $13.8 billion. Sales are set to soar throughout our forecast period to $30.5 billion by 2025, driven by uptake of both current and emerging agents in multiple treatment settings. Two drug classes, HER2-targeted agents and CDK4/6 inhibitors, will account for over 60% of sales in this market in 2025.
Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead.
Source: Pharma Disease Insight: Oncology Breast Cancer PowerPoint document
Pharma Disease Insight: Oncology Breast Cancer
This business document is categorized under the function(s): None specified.
File Size: 2 MB
Number of Slides: 31
Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document.
Initial upload date (first version): Jun 8, 2017
Ask the Author a Question
Log In Below
Report this Document
Please explain why the content is inappropriate and provide as much detail as possible. Possible reasons include, but are not limited, to the following:
Are you a business professional?
Just as the mobile apps market has helped software developers earn sustainable, passive income, we hope Flevy will do the same for business professionals, like yourself. There's no reason to let your IP collect dust when it can be making you perpetual income.
CUSTOMERS ALSO BOUGHT THESE DOCUMENTS